Chanelle Pharma has appointed Sébastien Boussemart as its head of animal health, a strategic leadership role designed to accelerate the company’s growth, strengthen global operations, and advance its vision as a fully integrated B2B partner of choice for the animal health industry.
In this role, Mr Boussemart will lead the animal health division, overseeing the end-to-end business from development and manufacturing to commercialisation.
Angelo Gatto, chief executive of Chanelle Pharma, said: “Sébastien joins us at an exciting moment. The NEW Chanelle is evolving into a global and fully integrated player, combining development, manufacturing, and commercialisation under one roof.
“His international history in animal health and proven leadership will be pivotal as we accelerate innovation and create long-term value for our partners.”
Mr Boussemart added: “I am thrilled to join Chanelle Pharma at such a transformative time. The company’s vision to expand the end-to-end B2B partnership is unique in the industry.
“I look forward to leading the animal health business, supporting our talented teams, and helping our partners access reliable, high-quality solutions while unlocking new growth opportunities.”
